Agreement between an in‐house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to <scp>HIV</scp>‐1 protease, reverse transcriptase, and integrase inhibitors
Francesco Saladini(University of Siena), Maurizio Zazzi(University of Siena)
Cited by 26
Related Papers
Residual phenotypic susceptibility to doravirine in multidrug-resistant HIV-1 from subjects enrolled in the PRESTIGIO Registry
|International Journal of Antimicrobial Agents|2023|6